2021
Reflections on Anthony Zietman From Gastrointestinal Cancer and Physics Editors
Willett GCECG, Chang DT, Czito BG, Liauw SL, Wo JY, Klein PEE, Chen Z, Carlson DJ, Chetty IJ. Reflections on Anthony Zietman From Gastrointestinal Cancer and Physics Editors. International Journal Of Radiation Oncology • Biology • Physics 2021, 111: 1114-1117. PMID: 34793734, DOI: 10.1016/j.ijrobp.2021.09.007.Peer-Reviewed Original Research
2019
High-dose-rate brachytherapy as monotherapy for prostate cancer: The impact of cellular repair and source decay
Tien CJ, Carlson DJ, Nath R, Chen ZJ. High-dose-rate brachytherapy as monotherapy for prostate cancer: The impact of cellular repair and source decay. Brachytherapy 2019, 18: 701-710. PMID: 31109870, DOI: 10.1016/j.brachy.2019.04.005.Peer-Reviewed Original ResearchThe ASTRO Research Portfolio: Where Do We Go From Here?
Yu JB, Beck TF, Anscher MS, Baschnagel AM, Brock KK, Carlson DJ, Dominello MM, Kimple RJ, Knisely JPS, Mendonca MS, Mian OY, Singh AK, Moros EG, Keen JC. The ASTRO Research Portfolio: Where Do We Go From Here? International Journal Of Radiation Oncology • Biology • Physics 2019, 103: 308-309. PMID: 30647008, DOI: 10.1016/j.ijrobp.2018.09.009.Peer-Reviewed Original Research
2010
Hypofractionation Results in Reduced Tumor Cell Kill Compared to Conventional Fractionation for Tumors With Regions of Hypoxia
Carlson DJ, Keall PJ, Loo BW, Chen ZJ, Brown JM. Hypofractionation Results in Reduced Tumor Cell Kill Compared to Conventional Fractionation for Tumors With Regions of Hypoxia. International Journal Of Radiation Oncology • Biology • Physics 2010, 79: 1188-1195. PMID: 21183291, PMCID: PMC3053128, DOI: 10.1016/j.ijrobp.2010.10.007.Peer-Reviewed Original ResearchConceptsTumor cell killingTumor hypoxiaCell killingRadiation fractionation schemesTumor biological effective doseBiological effective doseTumor cell killRegions of hypoxiaRadiotherapy regimenTreatment failureConventional fractionationNeck cancerStandard fractionationProstate cancerTumor cell populationFractionation schemeRadiation therapyTumor clonogensTumor oxygenationBlood vessels resultsCell killEffective doseAlternate fractionationResistant cellsHypoxia
2009
DMLC motion tracking of moving targets for intensity modulated arc therapy treatment – a feasibility study
Zimmerman J, Korreman S, Persson G, Cattell H, Svatos M, Sawant A, Venkat R, Carlson D, Keall P. DMLC motion tracking of moving targets for intensity modulated arc therapy treatment – a feasibility study. Acta Oncologica 2009, 48: 245-250. PMID: 18720056, DOI: 10.1080/02841860802266722.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply